Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06865781 · ClinicalTrials.gov registry record · NA
Vital Signs Reduction Study
A NA study of Hospitalization, sponsored by Intermountain Health Care.
- Active
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT06865781: Active NA study of Hospitalization, sponsored by Intermountain Health Care.
NCT06865781 is a NA study of Hospitalization that is active but no longer recruiting, run by Intermountain Health Care. The registered enrollment target is 160 participants, below the 500-participant average among 3 other Hospitalization trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06865781, a NA study of Hospitalization, is active but no longer recruiting, sponsored by Intermountain Health Care.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
Overnight vital signs are typically done every four hours on pediatric acute care units, despite limited evidence supporting the efficacy of this practice. Additionally, vital signs are often ordered and collected without considering the patient's clinical status or the potential impact that they may have on sleep. The purpose of this study is to understand the effect of forgone overnight vital signs on sleep quality and duration among children hospitalized in medical-surgical units, compared with children who receive standard of care vital signs.
Primary Outcome
Measured by actigraphy
Conditions Studied
Interventions
- OTHER Forgone overnight vital signs
Study Locations (1)
Utah
- Intermountain Primary Children's Hospital - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2024-07-17 |
| Est. Completion | 2025-11-30 |
| Phase | NA |
What the registry record for NCT06865781 still lists
NCT06865781 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 500-participant average among 3 other Hospitalization trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Hospitalization appearing as the primary indexed condition, and to 1 intervention - of which Forgone overnight vital signs is the first listed.
NCT06865781 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT06865781 about?
NCT06865781 is a clinical study titled "Vital Signs Reduction Study". Overnight vital signs are typically done every four hours on pediatric acute care units, despite limited evidence supporting the efficacy of this practice. Additionally, vital signs are often ordered and collected without considering the patient's clinical status or the potential impact that they ma...
What is the current status of trial NCT06865781?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2024-07-17. Estimated completion is 2025-11-30.
What conditions does trial NCT06865781 study?
This clinical trial studies the following conditions: Hospitalization.
What interventions are being tested in trial NCT06865781?
The interventions under investigation include: Forgone overnight vital signs (OTHER).
Who is sponsoring clinical trial NCT06865781?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06865781 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hospitalization
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Patient Selected Visual Art in the Hospital Room During Antepartum Admission on Hospital Satisfaction Scores and Patient Experience
RECRUITING · NA
-
Assessment of a Medication Reconciliation Program on Transitional Care
COMPLETED · NA
-
A Pragmatic Cluster Randomized Controlled Trial to Standardize Attending Morning Rounds in Medicine
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI